Revenue Growth and Brand Performance
Q1 global net revenue $73.1M, up 7% year-over-year; Jeuveau contributed $66.4M (positive unit growth and pricing stability) and Evolisse $6.7M. Jeuveau U.S. market share maintained at 14% with expected high single-digit YoY growth over the comparable period.
Profitability Momentum
Second consecutive quarter of positive adjusted EBITDA: Q1 adjusted EBITDA $0.6M vs a loss of $5.5M in the prior-year period (improvement of ~$6.1M), and company reiterates expectation of full-year adjusted EBITDA profitability in 2026.
Healthy Margins
Reported gross margin in Q1 was 67% and adjusted gross margin was 68% (adjusted excludes amortization of intangibles); full-year adjusted gross margin guidance of 65.5%–67% reiterated.
Commercial Reach and Engagement
Total purchasing accounts rose by nearly 500 in Q1; since launch >18,000 customers have purchased, including ~3,500 for Evolisse. U.S. account penetration above 60% and reorder rates ~71%.
Digital Ecosystem and Loyalty Growth
Evolus, Inc. Rewards approaching 1.5M members, up 27% YoY, with >255,000 redemptions in the quarter; company is embedding AI into its unified data platform to drive field productivity and targeted engagement.
Pipeline and International Expansion
Sculp FDA approval expected in Q4 2026 (key mid-face HA product); Esteem launch in Europe mid-May expands addressable market and is expected to support future U.S. launches and portfolio momentum.
Liquidity and Capital Flexibility
Cash and cash equivalents $49.8M at quarter-end, plus access to an additional $120M in capital ($100M term facility and $20M revolver); term loan maturity mid-2030 and modest cash usage (~$3M over prior two quarters).
Guidance and Long‑Term Outlook Reiterated
Full-year 2026 guidance reiterated: total net revenue $327M–$337M, non-GAAP operating expenses $210M–$216M, adjusted gross margin 65.5%–67%, and low- to mid-single-digit adjusted EBITDA margin; long-term double-digit revenue growth and margin expansion through 2028 reiterated.